Publication

Article

BioPharm International

BioPharm International-12-16-2013
Volume2013 eBook
Issue 1

Strategic Outsourcing in Clinical Development

Author(s):

Paul Nelles

Partnering with CDMOs can help bridge the innovation gap.

Partnering with CDMOs can help bridge the innovation gap.
 

Read this article

from BioPharm International’s 2013 Innovation Updates and Strategies eBook.

 

 

 

 

 

 

Articles in this issue
BPsupp1213_AmbrexProfile_200.jpg
Creating Better Medicines through Better Conjugation
BPsupp1213_Patent_200.jpg
Recovering Patent Life with Patent Term Extension
BPsupp1213_Vetter_200.jpg
Strategic Outsourcing in Clinical Development
BPsupp1213_NPSPharma_200.jpg
Leveraging Development Strengths Drives Therapies to Market
BPsupp1213_Kalypso_200.jpg
Driving Innovation in Biopharmaceuticals
BPsupp1213_Crowdfunding_200.jpg
Crowdfunding Biopharmaceutical Innovation

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
Related Content
Drug manufacturing process. Conveyor with medical ampoules line at a modern pharmaceutical plant. Pharmacology production, medicine industry from laboratory 2 factory, pharmacy. Healthcare, pharma 3D | Image Credit: © Corona Borealis - © Corona Borealis - stock.adobe.com
September 12th 2025

PDA 2025: How Strategic CAPA Builds Anti-Fragile Manufacturing Compliance

Feliza Mirasol
Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?
September 12th 2025

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
Hand touching Telecommunication network and wireless mobile internet technology with 5G LTE data connection of global business, fintech, blockchain. | Image Credit: © greenbutterfly - © greenbutterfly - stock.adobe.com
September 12th 2025

PDA 2025: Leveraging AI for GxP Compliance in Drug Production

Feliza Mirasol
Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically
September 12th 2025

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
Lymphocytes such as T cells, B cells are part of the immune system | Image Credit: © Artur - © Artur - stock.adobe.com
September 12th 2025

The Manufacturing Journey of CAR-T Cellular Therapy—An Overview

Shada Warreth
Background with viruses. Adeno-associated virus serotype 1. Virus is used as a vector for gene therapy. A model is built using data of viral macromolecular structure from Protein Data Bank (PDB 3NG9) | Image Credit: © Dr_Microbe - © Dr_Microbe - stock.adobe.com
September 12th 2025

AAV Manufacturing Partnership Supports Gene Therapy for CLN2 Batten Disease

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.